SCHEMBL8282927

SCHEMBL8282927

CC(C)C[C@H](N)C1(c2ccc(I)cc2)CCC1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.70
ALOX15 P16050 2/20 0.70
TSHR P16473 2/20 0.70
TP53 P04637 1/20 0.70
SLC6A4 P31645 14/20 0.66
SLC6A3 Q01959 14/20 0.66
SLC6A2 P23975 8/20 0.57
CHRM2 P08172 1/20 0.46
ADRA2A P08913 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
HTR2A P28223 1/20 0.46
OPRK1 P41145 1/20 0.46
HTR2B P41595 1/20 0.46
KCNH2 Q12809 1/20 0.46
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13515587 1.00 CYP3A4 (0.70) CYP3A4ALOX15TSHRTP53SLC6A4
SCHEMBL12235320 0.85 CYP3A4 (0.72) CYP3A4ALOX15TSHRTP53SLC6A4
SCHEMBL2378403 0.84 CYP3A4 (0.97) CYP3A4ALOX15TSHRTP53SLC6A4
SCHEMBL2379467 0.84 CYP3A4 (0.97) CYP3A4ALOX15TSHRTP53SLC6A4
SCHEMBL871577 0.84 CYP3A4 (0.70) CYP3A4ALOX15TSHRTP53SLC6A4
SCHEMBL682189 0.84 CYP3A4 (0.97) CYP3A4ALOX15TSHRTP53SLC6A4
SCHEMBL2270713 0.84 CYP3A4 (0.70) CYP3A4ALOX15TSHRTP53SLC6A4
SCHEMBL9115421 0.83 CYP3A4 (0.69) CYP3A4ALOX15TSHRTP53SLC6A4
Water SCHEMBL10423764 0.83 CYP3A4 (0.94) CYP3A4ALOX15TSHRTP53SLC6A4
Hydrochloric Acid SCHEMBL2105 0.83 CYP3A4 (1.00) CYP3A4ALOX15TSHRTP53SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742624-B1 DOPAMINE-AGONIST COMBINATION THERAPY WITH SEDATIVES FOR IMPROVING SLEEP QUALITY SEPRACOR INC (US) 2010-01-06 EP disclosed
WO-2005079851-A2 DOPAMINE-AGONIST COMBINATION THERAPY WITH SEDATIVES FOR IMPROVING SLEEP QUALITY SEPRACOR, INC. (US) 2005-09-01 WO disclosed